Cost-benefit analysis of a new alcohol biomarker, carbohydrate deficient transferrin, in a chronic illness primary care sample

Alcoholism: Clinical and Experimental Research

Volumn 29, Issue 11, 2005, Pages 2008-2014

  Dillie, Kathryn Sullivan ^a   Mundt, Marlon ^a   French, Michael T ^b   Fleming, Michael F ^a,c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c NONE   (United States)

Author keywords

Alcohol Biomarkers; Alcohol Screening; CDT; Cost Benefit Analysis

Indexed keywords

ALCOHOL; BIOLOGICAL MARKER; CARBOHYDRATE DEFICIENT TRANSFERRIN;

ALCOHOLISM; ARTICLE; CHRONIC DISEASE; COST BENEFIT ANALYSIS; COST CONTROL; DECISION THEORY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRINKING BEHAVIOR; HEALTH CARE COST; HEALTH SURVEY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; MONTE CARLO METHOD; PATIENT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PUBLICATION; SCREENING; SELF REPORT;

ADULT; ALCOHOL DRINKING; ALCOHOLISM; BIOLOGICAL MARKERS; CHRONIC DISEASE; COST OF ILLNESS; COST SAVINGS; COST-BENEFIT ANALYSIS; DECISION TREES; DIABETES MELLITUS; FEMALE; HEALTH CARE COSTS; HEALTH STATUS; HUMANS; HYPERTENSION; MALE; MASS SCREENING; MONTE CARLO METHOD; PRIMARY HEALTH CARE; SENSITIVITY AND SPECIFICITY; TRANSFERRIN;

EID: 29044435772     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.alc.0000187606.54854.db     Document Type: Article

References (38)

1. Aertgeerts B, Buntinx F, Ansoms S, Fevery J (2001) Screening properties of questionnaires and laboratory tests for the detection of alcohol abuse or dependence in a general practice population. Br J Gen Pract March: 206-217.
2. Ajani U, Gaziano M, Lotufo P, Liu S, Hennekens C, Buring J, Manson J (2000) Alcohol consumption and risk of coronary heart disease by diabetes status. Circulation 102:500-505.
3. Anderson P, Cremona A, Paton A, Turner C, Wallace P (1993) The risk of alcohol. Addiction 88:1493-1508.
4. Anton R, Lieber C, Tabakoff B, CDTect Study Group, (2002) Carbohydrate-Deficient Transferrin and gamma-Glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study. Alcohol Clin Exp Res 26:1215-1222.
5. Bean P (1999) Carbohydrate-deficient transferrin in the assessment of harmful alcohol consumption: diagnostic performance and clinical significance. Addiction Biology 4:151-161.
6. Bertholet N Daeppen JB, Wietlisbach V, Fleming MF, Burnand B (2005) Brief alcohol intervention in primary care reduces alcohol consumption: systematic review and meta-analysis. Archives of Internal Medicine In press.
7. Boardman A, Greenberg D, Vining A, Weimer D (2000) Dealing with uncertainty, in Cost-Benefit Analysis: Concepts and Practice, pp 185-187. Prentice Hall, Upper Saddle River, NJ.
8. Burke V, Puddey IB, Rakic V, Swanson NR, Dimmitt SB, Beilin LJ, Ching S, Beilby JP (1998) Carbohydrate-deficient transferrin as a marker of change in alcohol intake in men drinking 20 to 60g of alcohol per day. Alcohol Clin Exp Res 22:1973-1980.
9. Byrd WF (1997) Detecting alcohol abuse: the value of carbohydrate- deficient transferrin. J Insur Med 29:125-134.
10. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion. Behavioral Risk Factor Surveillance System. Available at: http://www.cdc.gov/brfss. Accessed June, 2005.
11. Conigrave KM, Degenhardt LJ, Whitfield JB, Saunders JB, Helander A, Tabakoff B (2002) CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. Alcohol Clin Exper Res 26:332-339.
12. Dawson DA (2000) US low-risk drinking guidelines: an examination of four alternatives. Alcohol Clin Exp Res 24 (12):1820-1829.
13. Department of Health and Human Services. 42 CFR Part 410: Medical Program; Negotiated Rulemaking: Coverage and Administrative Policies for Clinical Diagnostic Laboratory Services; Final Rule. In Federal Register. Friday, November 2001;23:2001.
14. D'Onofrio G, Degutis LC (2002) Preventive care in the emergency department: screening and brief intervention for alcohol problems in the emergency department: a systematic review. Acad Emerg Med 9:9627-9638.
15. Drummond MF (1997) Cost-effectiveness analysis in Methods for the Economic Evaluation of Health Care Programmes, pp. 96-138. Oxford University Press Oxford.
16. Fiore MC, Fleming MF, Burns ME (1999) Tobacco and Alcohol abuse: clinical opportunities for effective intervention. Proc Ass Am Phys 111:131-140.
17. Fleming MF, Barry KL, Manwell LB, Johnson K, London R (1997) Brief physician advice for problem alcohol drinkers: a randomized controlled trial in community-based primary care practices. JAMA 277:1039-1045.
18. Fleming MF, Brown RT, Brown D (2004) The efficacy of a brief alcohol intervention combined with %CDT levels in patients being treated for type II diabetes and/or hypertension. J Stud Alcohol 9:631-637.
19. th ed., pp. 429-477. McGraw-Hill Publishers, New York.
20. Fleming MF, Mundt M (2004) Carbohydrate deficient transferrin: validity of a new alcohol biomarker in a sample of diabetic and hypertensive patients. J Am Board Fam Pract 17:247-255.
21. Fleming MF, Mundt MP, French MT, Manwell LB, Stauffacher EA, Barry KL (2002) Brief Physician Advice for Problem Drinkers: long-term efficacy and benefit-cost analysis. Alcohol Clin Exp Res 26:36-43.
22. Harford TC, Grant BF, Yi HY, Chen CM (2005 May) Patterns of DSM-IV alcohol abuse and dependence criteria among adolescents and adults: results from the 2001 National Household Survey on Drug Abuse. Alcohol Clin Exp Res 29:810-828.
23. Helander A, Fors M, Zakrisson B (2001) Study of Axis-shield new CDT immunoassay for quantification of carbohydrate-deficient transferrin (CDT) in serum. Alcohol Alcohol 36:406-412.
24. Hermansson U, Helander A, Huss A, Brandt L, Ronnberg S (2000) The Alcohol Use Disorders Identification Test (AUDIT) and carbohydrate-deficient transferrin (CDT) in a routine workplace health examination. Alcohol Clin Exp Res 24:180-187.
25. Kao WH, Puddey IB, Boland LL, Watson RL, Brancati FL (2001) Alcohol consumption and the risk of Type 2 diabetes mellitus: atherosclerosis risk in communities study. Am J Epidemiol 154:748-757.
26. Lorie J, Sox H (1999) Principles of Medical Decision Making. Spine 24:493-498.
27. Meerkerk GJ, Njoo KH, Bongers MB, Trienekens P, Van Oers JAM (1999) Comparing the diagnostic accuracy of carbohydrate-deficient transferrin, gamma glutamyl transferase, and mean cell volume in a general practice population. Alcohol Clin Exp Res 23:1052-1059.
28. Moyer A, Finney JW, Swearingen CE, Vergun P (2002) Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations. Addiction 97:279-292.
29. Numminen H, Hillborn M, Juvela S (1996) Platelets, alcohol consumption, and onset of brain infarction. J Neurol Neurosurg Psychiatry 61:376-380.
30. Papa A, Tursi A, Cammarota G, Certo M, Cuoco L, Montalto M, Cianci R, Cianci R, Papa V, Fedelil P, Fedeli G, Gasbarrini G (1998) Effect of moderate and heavy alcohol consumption on intestinal transit time. Panminerva Med 40:183-185.
31. Sox H (1988) Expected value decision making, in Medical Decision Making, pp 150-166. Butterworths, Boston.
32. Spies CD, Kissner M, Neumann T, Blum S, Voigt C, Funk T, Runkel N,Pragst F (1998) Elevated carbohydrate-deficient transferring predicts prolonged intensive care unity stay in traumatized men. Alcohol 33:661-669.
33. Tonnesen H, Carstensen M, Maina P (1999) Is carbohydrate-deficient transferrin a useful marker of harmful alcohol intake among surgical patients? Eur J Surg 165:522-527.
34. Urbano-Marquez A, Estruch R, Fernandez-Sola J, Nicolas JM, Pare JC, Rubin E (1995) The greater risk of alcoholic cardiomyopathy and myopathy in women compared with men. JAMA 274:149-154.
35. Weathermon R, Crabb DW (1999) Alcohol and Medication Interactions, Alcohol Hlth Res World 23:40-54.
36. Wei M, Gibbons LW, Mitchell TL, Kanpert JB, Blair SN (2000) Alcohol Intake and incidence of type 2 diabetes in men. Diabetes Care 23:18-22.
37. Wetterling T, Kanitz R, Renner F, Fischer D (1998) Does carbohydrate-deficient transferrin predict the severity of alcohol withdrawal syn drome? Alcohol Clin Exp Res 22:1053-1056.
38. Whitlock V, Green C, Polen M, Orleans T, Klein JK (2004) Behavioral counseling interventions in primary care to reduce risky harmful alcohol use. Ann Intern Med 140:557-580.